查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1871991

经导管主动脉瓣置换术（TAVI）用脑栓塞保护装置：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Cerebral Embolic Protection Devices for TAVI - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 95 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年，全球用于经导管主动脉瓣置换术 (TAVI) 的脑栓塞保护装置的市场规模估计为 1.04 亿美元，预计到 2031 年将达到 3.84 亿美元，在预测期（2025-2031 年）内，复合年增长率为 19.9%。

本报告对近期经导管主动脉瓣置换术 (TAVR) 脑栓塞保护装置的关税调整和国际战略应对措施进行了全面评估，包括跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组。

经导管主动脉瓣置换术（TAVI），也称为经导管主动脉瓣置换术（TAVR），用于治疗主动脉瓣狭窄（AS）。对于不适合或手术风险极高的重度主动脉瓣狭窄患者，经导管主动脉瓣置换术是首选治疗方法。然而，TAVI 的益处会被中风的发生所抵消，中风会导致严重的残疾，并增加死亡率和生活品质的早期下降。儘管 TAVI 技术不断进步，但中风仍然是一个重要的併发症，并与严重的不良后果相关。大多数中风发生在手术全期术后的急性期，此时脑栓塞较为常见。脑栓塞保护装置（CEPD）的研发旨在最大限度地降低 TAVI 术中缺血性中风的风险。

经导管主动脉瓣置换术（TAVI）是一种微创治疗方法，适用于高风险老年患者和有手术风险的患者。近年来，TAVI已成为心血管领域的重大突破。 TAVI技术不仅显着提高了瓣膜置换治疗的安全性和有效性，也显着改善了患者的生活品质。然而，TAVI手术仍有一定的风险，尤其是脑栓塞的风险，这仍然是临床治疗中面临的持续挑战。为了有效降低TAVI手术过程中可能发生的脑栓塞事件，脑栓塞保护装置（CEPD）应运而生，成为确保TAVI治疗安全性和病人预后的重要技术手段。

随着经导管主动脉瓣置换术（TAVI）技术的日益普及和广泛接受，市场对脑栓塞保护装置的需求也不断增长。在TAVI手术过程中，尤其是在经股动脉植入瓣膜时，瓣膜植入器或导管的操作可能导致微小血栓脱落，进而引发脑栓塞。此类脑栓塞事件可导致中风和其他神经系统併发症，影响患者预后。为了有效预防这种风险，脑栓塞保护装置（CEPD）应运而生，并迅速成为TAVI手术的标准配备。

脑

在全球范围内，经导管主动脉瓣置换术（TAVI）技术及相关保护装置的应用在欧美市场起步较早，且市场接受度较高。尤其是在美国，TAVI手术中常规使用脑栓塞保护装置的比例正在上升。在中国及其他亚洲地区，TAVI技术的普及也带动了对脑栓塞保护装置的市场需求。儘管与欧美市场相比，亚洲市场仍处于起步阶段，但医疗技术和健康理念的不断进步意味着其市场潜力巨大。

Venus Meditech（Keystone Heart）是全球最大的经导管主动脉瓣置换术（TAVI）脑栓塞保护装置製造商，市占率超过90%。从区域来看，TAVI脑栓塞保护装置市场目前仅存在于欧洲和美国，其中北美约占55%的市占率。按动脉覆盖范围划分，非全动脉覆盖部分占据了超过90%的市场。按应用领域划分，医院应用约占全球市场份额的80%。

本报告旨在按地区/国家、类型和应用对全球经导管主动脉瓣置换术 (TAVI) 脑栓塞保护装置市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（单位）和收入（百万美元）为指标，对经导管主动脉瓣置换术（TAVI）脑栓塞保护装置的市场规模、估计值和预测进行了阐述，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。透过定量和定性分析，我们帮助读者制定TAVI脑栓塞保护装置的业务和成长策略，评估市场竞争情况，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Boston Scientific（Claret Medical）
  • Venus Medtech（Keystone Heart）
  • Transverse Medical
  • Emboline
  • Protembis GmbH
  • Filterlex Medical

按类型分類的细分市场

  • 全动脉应用
  • 非全动脉应用

应用领域

  • 医院
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Cerebral Embolic Protection Devices for TAVI was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 384 million by 2031 with a CAGR of 19.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cerebral Embolic Protection Devices for TAVI cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.

TAVI (transcatheter aortic valve implantation), as a minimally invasive treatment for high-risk elderly patients or patients with surgical risks, has become one of the important breakthroughs in the cardiovascular field in recent years. TAVI technology has not only significantly improved the safety and effectiveness of valve replacement therapy, but also greatly improved the quality of life of patients. However, there are certain risks in the TAVI operation, especially the risk of cerebral embolism, which has always been a challenge in clinical treatment. In order to effectively reduce the cerebral embolic events that may occur during TAVI surgery, cerebral embolic protection devices (CEPDs) came into being and became an important technical means to ensure the safety of TAVI treatment and patient prognosis.

At present, with the widespread application and acceptance of TAVI technology, the market demand for cerebral embolic protection devices is also growing. During TAVI surgery, especially when valve implantation is performed through the femoral artery, tiny blood clots may fall off due to the operation of the valve implanter and catheter, thereby causing cerebral embolism. This cerebral embolic event can cause stroke or other neurological complications, affecting the patient's prognosis. In order to effectively prevent this risk, CEPDs came into being and quickly became one of the standard configurations in TAVI surgery.

Brain

Globally, the European and American markets started early in the application of TAVI technology and related protection devices, and the market acceptance is high. Especially in the United States and Europe, more and more TAVI surgeries are beginning to routinely use cerebral embolic protection devices. In China and other Asian regions, with the gradual popularization of TAVI technology, the market demand for cerebral embolic protection devices is also rising. Although it is still in its infancy compared to the European and American markets, with the continuous advancement of medical technology and health concepts, the market potential is huge.

Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.

This report aims to provide a comprehensive presentation of the global market for Cerebral Embolic Protection Devices for TAVI, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cerebral Embolic Protection Devices for TAVI by region & country, by Type, and by Application.

The Cerebral Embolic Protection Devices for TAVI market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cerebral Embolic Protection Devices for TAVI.

Market Segmentation

By Company

  • Boston Scientific (Claret Medical)
  • Venus Medtech (Keystone Heart)
  • Transverse Medical
  • Emboline
  • Protembis GmbH
  • Filterlex Medical

Segment by Type

  • Total Artery Coverage
  • Non-total Artery Coverage

Segment by Application

  • Hopsital
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cerebral Embolic Protection Devices for TAVI manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Cerebral Embolic Protection Devices for TAVI Product Introduction
  • 1.2 Global Cerebral Embolic Protection Devices for TAVI Market Size Forecast
    • 1.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value (2020-2031)
    • 1.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume (2020-2031)
    • 1.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Price (2020-2031)
  • 1.3 Cerebral Embolic Protection Devices for TAVI Market Trends & Drivers
    • 1.3.1 Cerebral Embolic Protection Devices for TAVI Industry Trends
    • 1.3.2 Cerebral Embolic Protection Devices for TAVI Market Drivers & Opportunity
    • 1.3.3 Cerebral Embolic Protection Devices for TAVI Market Challenges
    • 1.3.4 Cerebral Embolic Protection Devices for TAVI Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Cerebral Embolic Protection Devices for TAVI Players Revenue Ranking (2024)
  • 2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Company (2020-2025)
  • 2.3 Global Cerebral Embolic Protection Devices for TAVI Players Sales Volume Ranking (2024)
  • 2.4 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Company Players (2020-2025)
  • 2.5 Global Cerebral Embolic Protection Devices for TAVI Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Cerebral Embolic Protection Devices for TAVI Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Cerebral Embolic Protection Devices for TAVI Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Cerebral Embolic Protection Devices for TAVI
  • 2.9 Cerebral Embolic Protection Devices for TAVI Market Competitive Analysis
    • 2.9.1 Cerebral Embolic Protection Devices for TAVI Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Cerebral Embolic Protection Devices for TAVI Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebral Embolic Protection Devices for TAVI as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Total Artery Coverage
    • 3.1.2 Non-total Artery Coverage
  • 3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type
    • 3.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Type (2020-2031)
    • 3.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type
    • 3.3.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Cerebral Embolic Protection Devices for TAVI Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hopsital
    • 4.1.2 Others
  • 4.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application
    • 4.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Application (2020-2031)
    • 4.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application
    • 4.3.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Cerebral Embolic Protection Devices for TAVI Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region
    • 5.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2020-2025)
    • 5.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2026-2031)
    • 5.1.4 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), (2020-2031)
  • 5.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region
    • 5.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2020-2025)
    • 5.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2026-2031)
    • 5.2.4 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.4.2 North America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.5.2 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.7.2 South America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.3.2 United States Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.4.2 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.5.2 China Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.6.2 Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.7.2 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.9.2 India Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Boston Scientific (Claret Medical)
    • 7.1.1 Boston Scientific (Claret Medical) Company Information
    • 7.1.2 Boston Scientific (Claret Medical) Introduction and Business Overview
    • 7.1.3 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.1.5 Boston Scientific (Claret Medical) Recent Development
  • 7.2 Venus Medtech (Keystone Heart)
    • 7.2.1 Venus Medtech (Keystone Heart) Company Information
    • 7.2.2 Venus Medtech (Keystone Heart) Introduction and Business Overview
    • 7.2.3 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.2.5 Venus Medtech (Keystone Heart) Recent Development
  • 7.3 Transverse Medical
    • 7.3.1 Transverse Medical Company Information
    • 7.3.2 Transverse Medical Introduction and Business Overview
    • 7.3.3 Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.3.5 Transverse Medical Recent Development
  • 7.4 Emboline
    • 7.4.1 Emboline Company Information
    • 7.4.2 Emboline Introduction and Business Overview
    • 7.4.3 Emboline Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Emboline Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.4.5 Emboline Recent Development
  • 7.5 Protembis GmbH
    • 7.5.1 Protembis GmbH Company Information
    • 7.5.2 Protembis GmbH Introduction and Business Overview
    • 7.5.3 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.5.5 Protembis GmbH Recent Development
  • 7.6 Filterlex Medical
    • 7.6.1 Filterlex Medical Company Information
    • 7.6.2 Filterlex Medical Introduction and Business Overview
    • 7.6.3 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.6.5 Filterlex Medical Recent Development

8 Industry Chain Analysis

  • 8.1 Cerebral Embolic Protection Devices for TAVI Industrial Chain
  • 8.2 Cerebral Embolic Protection Devices for TAVI Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Cerebral Embolic Protection Devices for TAVI Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Cerebral Embolic Protection Devices for TAVI Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Cerebral Embolic Protection Devices for TAVI Market Trends
  • Table 2. Cerebral Embolic Protection Devices for TAVI Market Drivers & Opportunity
  • Table 3. Cerebral Embolic Protection Devices for TAVI Market Challenges
  • Table 4. Cerebral Embolic Protection Devices for TAVI Market Restraints
  • Table 5. Global Cerebral Embolic Protection Devices for TAVI Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Company (2020-2025)
  • Table 7. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Company (2020-2025) & (Units)
  • Table 8. Global Cerebral Embolic Protection Devices for TAVI Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Cerebral Embolic Protection Devices for TAVI Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Cerebral Embolic Protection Devices for TAVI Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Cerebral Embolic Protection Devices for TAVI Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Cerebral Embolic Protection Devices for TAVI
  • Table 13. Global Cerebral Embolic Protection Devices for TAVI Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebral Embolic Protection Devices for TAVI as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
  • Table 22. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2020-2025) & (Units)
  • Table 23. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2026-2031) & (Units)
  • Table 24. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Cerebral Embolic Protection Devices for TAVI Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Cerebral Embolic Protection Devices for TAVI Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
  • Table 34. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2020-2025) & (Units)
  • Table 35. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2026-2031) & (Units)
  • Table 36. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Cerebral Embolic Protection Devices for TAVI Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Cerebral Embolic Protection Devices for TAVI Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (Units): 2020 VS 2024 VS 2031
  • Table 46. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2020-2025) & (Units)
  • Table 47. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2026-2031) & (Units)
  • Table 48. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume, (2020-2025) & (Units)
  • Table 56. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume, (2026-2031) & (Units)
  • Table 57. Boston Scientific (Claret Medical) Company Information
  • Table 58. Boston Scientific (Claret Medical) Introduction and Business Overview
  • Table 59. Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 61. Boston Scientific (Claret Medical) Recent Development
  • Table 62. Venus Medtech (Keystone Heart) Company Information
  • Table 63. Venus Medtech (Keystone Heart) Introduction and Business Overview
  • Table 64. Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 66. Venus Medtech (Keystone Heart) Recent Development
  • Table 67. Transverse Medical Company Information
  • Table 68. Transverse Medical Introduction and Business Overview
  • Table 69. Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 71. Transverse Medical Recent Development
  • Table 72. Emboline Company Information
  • Table 73. Emboline Introduction and Business Overview
  • Table 74. Emboline Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Emboline Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 76. Emboline Recent Development
  • Table 77. Protembis GmbH Company Information
  • Table 78. Protembis GmbH Introduction and Business Overview
  • Table 79. Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 81. Protembis GmbH Recent Development
  • Table 82. Filterlex Medical Company Information
  • Table 83. Filterlex Medical Introduction and Business Overview
  • Table 84. Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 86. Filterlex Medical Recent Development
  • Table 87. Key Raw Materials Lists
  • Table 88. Raw Materials Key Suppliers Lists
  • Table 89. Cerebral Embolic Protection Devices for TAVI Downstream Customers
  • Table 90. Cerebral Embolic Protection Devices for TAVI Distributors List
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Cerebral Embolic Protection Devices for TAVI Product Picture
  • Figure 2. Global Cerebral Embolic Protection Devices for TAVI Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Cerebral Embolic Protection Devices for TAVI Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Cerebral Embolic Protection Devices for TAVI Sales Volume (2020-2031) & (Units)
  • Figure 5. Global Cerebral Embolic Protection Devices for TAVI Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Cerebral Embolic Protection Devices for TAVI Report Years Considered
  • Figure 7. Global Cerebral Embolic Protection Devices for TAVI Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Cerebral Embolic Protection Devices for TAVI Players Sales Volume Ranking (2024) & (Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cerebral Embolic Protection Devices for TAVI Revenue in 2024
  • Figure 10. Cerebral Embolic Protection Devices for TAVI Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Total Artery Coverage Picture
  • Figure 12. Non-total Artery Coverage Picture
  • Figure 13. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Cerebral Embolic Protection Devices for TAVI Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
  • Figure 16. Global Cerebral Embolic Protection Devices for TAVI Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Cerebral Embolic Protection Devices for TAVI Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hopsital
  • Figure 19. Product Picture of Others
  • Figure 20. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 21. Global Cerebral Embolic Protection Devices for TAVI Sales Value Market Share by Application, 2024 & 2031
  • Figure 22. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
  • Figure 23. Global Cerebral Embolic Protection Devices for TAVI Sales Volume Market Share by Application, 2024 & 2031
  • Figure 24. Global Cerebral Embolic Protection Devices for TAVI Price by Application (2020-2031) & (US$/Unit)
  • Figure 25. North America Cerebral Embolic Protection Devices for TAVI Sales Value (2020-2031) & (US$ Million)
  • Figure 26. North America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Europe Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), 2024 VS 2031
  • Figure 31. South America Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. South America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value (%), (2020-2031)
  • Figure 36. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume (%), (2020-2031)
  • Figure 37. United States Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. United States Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 39. United States Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Europe Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 43. China Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. China Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 45. China Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Japan Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 49. South Korea Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 51. South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 54. Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 55. India Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. India Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 57. India Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 58. Cerebral Embolic Protection Devices for TAVI Industrial Chain
  • Figure 59. Cerebral Embolic Protection Devices for TAVI Manufacturing Cost Structure
  • Figure 60. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed